Showing results (561-570 of 1,609) with videos related to

Sort By:
Pageof 161
JAMA Oncology|December 30, 2016
A Standard Set of Value-Based Patient-Centered Outcomes for Breast Cancer: The International Consortium for Health Outcomes Measurement (ICHOM) InitiativeWee Loon Ong, Maartje G Schouwenburg, Annelotte C M van Bommel, et al.
JAMA Oncology|October 14, 2016
A Comparison of Prognostic Ability of Staging Systems for Human Papillomavirus-Related Oropharyngeal Squamous Cell CarcinomaZain A Husain, Tiange Chen, Christopher D Corso, et al.
JAMA Oncology|November 20, 2015
Long-term Risk of Hospitalization for Somatic Diseases in Survivors of Adolescent or Young Adult CancerKathrine Rugbjerg, Jørgen H Olsen
JAMA Oncology|August 7, 2015
Differences in the Acute Toxic Effects of Breast Radiotherapy by Fractionation Schedule: Comparative Analysis of Physician-Assessed and Patient-Reported Outcomes in a Large Multicenter CohortReshma Jagsi, Kent A Griffith, Thomas P Boike, et al.
JAMA Oncology|September 25, 2015
Use of Preoperative Magnetic Resonance Imaging for Breast Cancer: A Canadian Population-Based StudyAngel Arnaout, Christina Catley, Christopher M Booth, et al.
JAMA Oncology|September 25, 2015
Effectiveness of an Adjuvant Chemotherapy Regimen for Early-Stage Breast Cancer: A Systematic Review and Network Meta-analysisTakeo Fujii, Fanny Le Du, Lianchun Xiao, et al.
JAMA Oncology|September 11, 2015
Resource Utilization and Safety of Outpatient Management Following Intensive Induction or Salvage Chemotherapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Nonrandomized Clinical Comparative AnalysisJennifer E Vaughn, Megan Othus, Morgan A Powell, et al.
JAMA Oncology|October 30, 2015
Current Therapy and New Directions in the Treatment of Hairy Cell Leukemia: A ReviewAditya Sarvaria, Zheng Topp, Alan Saven
JAMA Oncology|October 27, 2015
Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate CancerMarianne Schmid, Christian P Meyer, Gally Reznor, et al.
JAMA Oncology|November 6, 2015
Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical TrialWilliam N William, Vassiliki Papadimitrakopoulou, J Jack Lee, et al.
Pageof 161